News – Page 1145 – Endpoints News

Kite adds promising leukemia responses in small CAR-T studies, then fires the starting gun on its rolling submission

9 years ago

What makes a PhII drug worth up to $665M? Researchers spell it out for Novartis

9 years ago

#ASH16: Pfizer offers a thumbs-up on OS data from PhII blood cancer study of glasdegib

9 years ago

In wake of a CAR-T restructuring, Novartis says it’s ready to hunt a pioneering OK for lead program

9 years ago

Spark’s delivery vector triggers another troubling immune reaction, but R&D team maintains hemophilia B efficacy

9 years ago

Lethally severe neurotoxicity continues to haunt Juno’s CAR-T pipeline

9 years ago

Celgene buys Acetylon, keeps what it wants and spins the rest back out as Regenacy

9 years ago

Yes, Martin Shkreli can drop his bad boy persona, at least for one moment

9 years ago

Retreating Arrowhead axes CSO in RNAi rout; Impel raises $36M for platform tech

9 years ago

21st Century Cures Act could use a second look; It's time for the FDA to open up

9 years ago

Booming CRISPR pioneer Intellia looks to double staff with new digs

9 years ago

Cutting back in the UK, Takeda spins out its top neuroscience team into a transatlantic biotech

9 years ago

Round 2 in Boehringer's US reorganization will claim another 244 jobs, including small molecule group

9 years ago

Magic mushrooms treat depression, anxiety felt by cancer patients; Merck wins a speedy review schedule for latest ...

9 years ago

Merck pulls the trigger on a new West Coast R&D campus in the heart of a mega-hub

9 years ago

A disruptive billionaire with a yen for innovation herds top researchers into a neoantigen cancer coalition

9 years ago

Star-crossed AstraZeneca strikes a drug discovery deal with upstart Bicycle

9 years ago

21st Century Cures Act supporters crush meager House opposition, head to a final showdown in the Senate

9 years ago

Bluebird, Celgene jump off to a promising start in the marathon race to develop a CAR-T for multiple myeloma

9 years ago

Heptares bags GPCR tech in $12M G7 buyout; Pfizer reports PhIII success for Herceptin biosim

9 years ago

In Lechleiter's final days, Eli Lilly flags upcoming job cuts in the wake of a PhIII implosion

9 years ago

Gut check: Newest microbiome startup concentrates on autism, Parkinson’s disease

9 years ago

Investigators prep PhIII in effort to move MDMA (you know it as ecstasy) off the street and into use for PTSD

9 years ago

Fresh enthusiasm for Cerecor sours as lead drug flops in PhII depression study, shares crater

9 years ago

First page Previous page 1142 1143 114411451146 1147 1148 Next page Last page